REPL vs RMD · $825.7M cap vs P/E 29, $37.68B cap
Replimune Group Inc (REPL) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
REPL does not have a complete income-statement cache yet.
RMD does not have a complete income-statement cache yet.
REPL currently screens at market cap $825.7M. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the REPL and RMD stock pages for the full models.
Not investment advice.